Cell Therapeutics (CTIC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC)

CTIC 9.090

0.0%

Jun 26 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: zeta1961 who wrote (334)	12/6/2004 2:22:18 PM
From: Icebrg	Read Replies (1) of 946

Zeta, These were really not new News - just a confirmation of what was already known. Apart from that the stock is suffering from Bianco bias. There was also a poster presentation at ASCO for a phase I/II study in relapsed/refractory indolent NHL. So far only very few patients have been treated. 22 to be exact. If these results can be repeated in a larger study they will be truly stunning. CTIC reported Cr/CRu 77%; PR 18%; SD 5%. All 22 patients responded! The poster is available in pdf-format at CTIC's web-site. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next